Author

Vanesa Garrido-Rodríguez

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

Proof-of-concept phase II study protocol to evaluate the efficacy and safety of prednisone in the treatment of idiosyncratic hepatotoxicity and its mechanistic pathways through an integrative analysis: the DILICORT clinical trial

Idiosyncratic drug-induced liver injury (DILI) is an unpredictable adverse reaction ranging from mild liver enzyme elevations to acute liver failure, with management largely limited to withdrawal of the causative drug. An international propensity score-matched study of 724 DILI cases associated corticosteroid thera...

Vanesa Garrido-Rodríguez, Á. Remesal-Doblado, Miren García-Cortés et al. · Frontiers in Pharmacology · 0 citations

Open access Aug 2026

Thymosin-α-1 plasma levels measured after acute SARS-CoV-2 infection are associated with the severity of infection

Thymalfasin, the synthetic form of Thymosin-α-1 (Tα1), which is a thymic peptide hormone with immunomodulatory properties, has been used in the treatment of severe cases of COVID-19, with inconclusive results. Plasma concentrations of Tα1 in COVID-19 patients have never been measured, nor have they been linked to t...

Israel Olivas-Martínez, M. Genebat, Á. Bulnes-Ramos et al. · Scientific Reports · 0 citations